Roche Buys 89bio: A $3.5B Biotech Bet
Markets & Money Today | 2 Min News | The Daily News Now! - Podcast autorstwa The Daily News Now! - Czwartki
Kategorie:
Roche buys 89bio for $2.4B in major pharma deal! The acquisition aims to boost Roche's pipeline of liver disease treatments and offset revenue losses from expiring patents. Will this acquisition accelerate new medicines and ensure Roche's growth? Hosted on Acast. See acast.com/privacy for more information.
